A new way to manufacture small batches of biopharmaceuticals on demand
System can be rapidly reconfigured to produce a variety of protein drugs.
System can be rapidly reconfigured to produce a variety of protein drugs.
Three MIT postdocs earn competitive Howard Hughes Medical Institute fellowships that support diversity in the sciences.
Tiny probes could be useful for monitoring patients with Parkinson’s and other diseases.
Matthew Vander Heiden seeks new cancer treatments that exploit tumor cells’ abnormal metabolism.
Biologists discover that the environment surrounding a cell plays an integral role in its ability to accurately segregate its chromosomes.
Findings suggest mechanisms for the persistence of nasal polyps and possible new treatment strategies.
The new Convergence Scholars Program bridges disciplines and helps young researchers further their skills and build their brands as scientists.
Unexpected findings show that the body’s own immune system destroys retinal cells.
With new method, surgeons would remove tumor, then implant microparticles that attack remaining cancer cells.
Faculty members recognized for excellence via a diverse array of honors, grants, and prizes over the last quarter.
Polymeric nanoparticles can efficiently administer mRNA to cells of the lungs, liver, and other organs.
Drugs carried in cellular “backpacks” help T cells to destroy tumors.
Researchers identify the amino acid aspartate as a metabolic limitation in certain cancers.
Shortfall of digestive enzymes can lead to tissue breakdown in early stages of pancreatic cancer.
Researchers generate an intestinal cell mimic that can be harnessed in studies of diseases such as inflammatory bowel disease.